国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2014年
1期
43-45
,共3页
血塞通%舒血宁%心绞痛
血塞通%舒血寧%心絞痛
혈새통%서혈저%심교통
Xuesetong%Shuxuening%Angina
目的 对比研究血塞通注射液和舒血宁注射液治疗冠心病心绞痛的临床疗效.方法 将2012年9月至2013年9月收治的80例冠心病心绞痛患者按不同用药方案随机均分为对照组(舒血宁注射液)和试验组(血塞通注射液),治疗12周后对两组治疗效果进行比较.结果 治疗12周后,试验组治疗显效率(62.5％)明显高于对照组(37.5％)(P＜0.05);两组治疗总有效率比较差异无统计学意义(P＞0.05);试验组患者TC、TG、LDLC三项血脂指标的平均水平明显低于对照组(P＜0.05);试验组患者硝酸甘油的每日用量明显少于对照组患者(P＜0.05).结论 血塞通注射液治疗冠心病心绞痛疗效显著,优于舒血宁注射液,值得临床推广应用.
目的 對比研究血塞通註射液和舒血寧註射液治療冠心病心絞痛的臨床療效.方法 將2012年9月至2013年9月收治的80例冠心病心絞痛患者按不同用藥方案隨機均分為對照組(舒血寧註射液)和試驗組(血塞通註射液),治療12週後對兩組治療效果進行比較.結果 治療12週後,試驗組治療顯效率(62.5％)明顯高于對照組(37.5％)(P＜0.05);兩組治療總有效率比較差異無統計學意義(P＞0.05);試驗組患者TC、TG、LDLC三項血脂指標的平均水平明顯低于對照組(P＜0.05);試驗組患者硝痠甘油的每日用量明顯少于對照組患者(P＜0.05).結論 血塞通註射液治療冠心病心絞痛療效顯著,優于舒血寧註射液,值得臨床推廣應用.
목적 대비연구혈새통주사액화서혈저주사액치료관심병심교통적림상료효.방법 장2012년9월지2013년9월수치적80례관심병심교통환자안불동용약방안수궤균분위대조조(서혈저주사액)화시험조(혈새통주사액),치료12주후대량조치료효과진행비교.결과 치료12주후,시험조치료현효솔(62.5％)명현고우대조조(37.5％)(P＜0.05);량조치료총유효솔비교차이무통계학의의(P＞0.05);시험조환자TC、TG、LDLC삼항혈지지표적평균수평명현저우대조조(P＜0.05);시험조환자초산감유적매일용량명현소우대조조환자(P＜0.05).결론 혈새통주사액치료관심병심교통료효현저,우우서혈저주사액,치득림상추엄응용.
Objective To compare the clinical efficacy between Xuesetong injection and Shuxuening injection in treating coronary heart disease angina.Methods 80 cases with coronary heart disease angina in our hospital from September 2012 to September 2013 were randomly divided into control group (Shuxuening injection) and experimental group (Xuesetong Injection),the efficacy of two groups were compared after 12 weeks of treatment.Results The significant efficiency of experimental group (62.5％) was higher than that of control group (37.5％) (P ＜ 0.05); there was no statistical significant difference in total effective-rate between the two groups (P ＞ 0.05); the plasma levels of TC,TG,LDLC in experimental group were lower than those in control group (P ＜ 0.05); the amount of nitroglycerin of experimental group was lower than that of control group (P ＜ 0.05).Conclusion Xuesetong injection has significant effects on treating coronary heart disease angina,which is better than Shuxuening injection,and it is worthy of clinical promotion widely.
